Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mitchell

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Acta Neurochirurgica|October 11, 2022
Radiological follow-up of endovascularly treated intracranial aneurysms: a survey of current practice in the UK and IrelandCathal John Hannan, Abdurrahman I Islim, Andrew F Alalade, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Acta Neurochirurgica|October 11, 2022
Radiological follow-up of endovascularly treated intracranial aneurysms: a survey of current practice in the UK and IrelandCathal John Hannan, Abdurrahman I Islim, Andrew F Alalade, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Pageof 12